Articles / Preparing for the next COVID wave
0 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
GPs should plan antivirals for high- risk patients
Technically we are still in a pandemic, but psychologically we have decided it’s over. That’s the verdict from Professor Nancy Baxter, Head of Melbourne University’s School of Population and Global Health.
“This is probably one of our lowest risk periods in a while. But there’s a smorgasbord of variants around the world at the moment, and it’s unclear if one’s going to become dominant or worse than BA.5,” Professor Baxter says.
“The next wave will likely come from the northern hemisphere when our immunity has declined, and it is already declining. In January it will be over six months since the BA.5 wave peaked, which is a long time since people had their primary immunisations or boosters.”
Professor Baxter urges GPs to make the most of the current lull and plan for antiviral treatments for the inevitable next wave, which could come as early as summer.
Menopausal Hormone Therapy - What Dose of Estrogen is Best?
Cardiovascular Benefits of GLP1s – New Evidence
Oral Contraceptive Pill in Teens
RSV and the Heart
Modified but kept in place
Eliminated entirely without replacement
Maintained as is
Completely replaced with an alternative system
Listen to expert interviews.
Click to open in a new tab
Browse the latest articles from Healthed.
Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.
Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.
Menopause and MHT
Multiple sclerosis vs antibody disease
Using SGLT2 to reduce cardiovascular death in T2D
Peripheral arterial disease